| Nov 19 |
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
|
| Nov 7 |
Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress
|
| Nov 6 |
Intra-Cellular bolsters Caplyta data with another Phase III win
|
| Nov 5 |
Intra-Cellular meets main goal in late stage trial for its schizophrenia treatment
|
| Nov 5 |
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
|
| Nov 2 |
Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results
|
| Nov 1 |
Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Oct 31 |
Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
|
| Oct 30 |
Intra-Cellular Therapies, Inc. (ITCI) Q3 2024 Earnings Call Transcript
|
| Oct 30 |
Intra-Cellular jumps on Q3 beat as Caplyta outlook brightens
|
